Updated June 11, 2021
The CRA, with input from the Canadian Arthritis Patient Alliance (CAPA) has developed a Decision Tool for COVID-19 Vaccination in Patients with Autoimmune Rheumatic Diseases.
Updates to the Tool include the addition of all vaccines currently approved for use by Health Canada, as well as a section on pediatric considerations.
You may reproduce and distribute an unedited copy of this document without additional permission.
A free-of-charge, editable form of the decision tool is also available by special request for adaptation to other populations, provided it is not for commercial interests and the decision tool will be made freely and publicly available. Requests can be made to the CRA by email at firstname.lastname@example.org.